{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for vitamin root_notes_note in Note (approximate match)
Status:
Investigational
Source:
INN:ifinatamab deruxtecan [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00590824: Phase 2 Interventional Completed Melanoma
(2007)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:pegenzileukin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:lipustobart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04692831: Phase 1 Interventional Active, not recruiting HER-2 Positive Malignant Carcinoma of Breast
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00004806: Phase 1 Interventional Completed Cystic Fibrosis
(1995)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
USAN:RINFABATE [USAN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04209114: Phase 3 Interventional Completed Bladder Cancer
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:sacituzumab tirumotecan [INN]
Source URL:
Class:
PROTEIN
